The Global Health Network The Global Health Network

www.tghn.org

Not a member?

Find out what The Global Health Network can do for you. Register now.

Less

Member Sites A network of members around the world. Join now.

Research Tools Resources designed to help you.

Building Teratovigilance Capacity in Africa

This was a unique workshop hosted by CIDER, The Centre for Infectious Disease Epidemiology & Research in the School of Public Health & Family Medicine, University of Cape Town, in October 2017.

The workshop's aims were to enable participants to:

1) Be able to analyse and apply the basic principles of teratology and pharmaco-epidemiology to investigate whether an exposure poses a potential risk to the mother and feotus at an individual and a population level

2) Acquire up-to-date information on various relevant teratogens

3) Acquire knowledge and skills required to design and implement teratogen surveillance systems in a resource-limited setting

4) Understand the importance and clinical application of product labelling around safety of medicines during pregnancy

5) Form part of network of African researchers, clinicians, regulators and policymakers to build capacity for protection of pregnant women and their infants

View presentations below and contact Dr Ushma Mehta (ushma.mehta@uct.ac.za) or Dr Emma Kalk (emma.kalk@uct.ac.za) for further information:

Introduction & principles of teratovigilance	Dr Ushma Mehta	CIDER, School of Public Health & Family Medicine, University of Cape Town, South Africa
Principles of teratology	Prof Lewis Holmes	Medical Genetics Unit, MassGeneral Hospital for Children & Dept of Paediatrics, Harvard Medical School & Director North American Antiepileptic Drug Pregnancy Registry, Boston, US
Principles of (pharmaco) epidemiology PENDING	Prof Landon Myer	CIDER, School of Public Health & Family Medicine, University of Cape Town, South Africa
Adverse birth outcomes other than birth defects: basic principles	Dr Amy Slogrove	CIDER, School of Public Health & Family Medicine, & Dept of Paediatrics & Child Health, University of Cape Town, South Africa
Beyond birth defects: the importance of other adverse birth outcomes in teratovigilance	Dr Rebecca Zash	Harvard TH Chan School of Public Health, US & Botswana Harvard AIDS Institute Partnership, Boston, US
Methods of gestational age assessment influence the observed association between ART exposure & preterm delivery: a prospective study in Cape Town	Ms Thoko Malaba	CIDER, School of Public Health & Family Medicine, University of Cape Town, South Africa
Determining the prevalence of congenital disorders in Africa: the example of South Africa	Dr Helen Malherbe	Genetic Alliance, South Africa
Ascertainment challenges of assembling a virtual PER based on routine data and data linkage	Prof Andrew Boulle	CIDER, School of Public Health & Family Medicine, University of Cape Town, South Africa
Resources & support: Teratology Information Services PENDING	Dr Laura Yates	Institute of Genetic Medicine, Newcastle University & UK Teratology Information Service, UK
Resources & support: The Global Health Network/Global Pharmacovigilance	Dr Elizabeth Allen	Division of Clinical Pharmacology, Department of Medicine, University of Cape Town
Congenital infections	Dr Lavinia Schuler-Faccini	Dept of Genetics, Federal University of Rio Grande do Sul, Brazil
The safety of ART in pregnancy	Dr Rebecca Zash	Harvard TH Chan School of Public Health, US & Botswana Harvard AIDS Institute Partnership, Boston, US
Transitioning to new ARVs: WHO 2017 Guidance PENDING	Dr Francoise Renaud	HIV/AIDS Dept, World Health Organisation
Teratogenic effects of diabetes	Dr Ed Coetzee	Division of Maternal Fetal Medicine, Dept of Obstetrics & Gynaecology, University of Cape Town, South Africa
Fetal Alcohol Spectrum Disorder (& illicit drugs)	Dr Mike Urban	Division of Molecular Biology & Human Genetics, Faculty of Medicine & Health Sciences, Stellenbosch University, South Africa
Important & emerging teratogens in the developing world	Dr Lavinia Schuler-Faccini	Dept of Genetics, Federal University of Rio Grande do Sul, Brazil
Drug use during pregnancy & potential for adverse pregnancy outcome PENDING	Dr Esperanca Sevene	Faculty of Medicine, Eduardo Mondlane University & Manhica Health Research Centre, Mozambique
Barriers to obtaining an accurate medicine exposure history in pregnancy	Dr Elizabeth Allen	Division of Clinical Pharmacology, Department of Medicine, University of Cape Town
Detecting teratogenic effects emerging after birth: challenges & tools	Dr Amy Slogrove	CIDER, School of Public Health & Dept of Paediatrics & Child Health, University of Cape Town, South Africa
Pregnancy registries PENDING	Prof Lewis Holmes	Medical Genetics Unit, MassGeneral Hospital for Children & Dept of Paediatrics, Harvard Medical School & Director North American Antiepileptic Drug Pregnancy Registry, Boston, US
WHO Central Registry for the epidemiological surveillance of drug safety in pregnancy	Dr Christine Halleux	Special Programmes for Research & Training in Tropical Diseases, World Health Organisation
Data management in teratovigilance research: experience from the WHO Central Registry	Dr Christine Halleux	Special Programmes for Research & Training in Tropical Diseases, World Health Organisation